Erratum to: CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

被引:0
|
作者
Jeremy Koppel
Valerie Vingtdeux
Philippe Marambaud
Cristina d’Abramo
Heidy Jimenez
Mark Stauber
Rachel Friedman
Peter Davies
机构
[1] Feinstein Institute for Medical Research,Litwin
[2] North-Shore Long Island Jewish Health System,Zucker Research Center
[3] Yeshiva University,undefined
[4] Queens College,undefined
来源
Molecular Medicine | 2014年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In volume 19, the Journal made an error in pagination for the two papers below (both begin with the same page number and share eight pages with the same page numbers):
引用
收藏
页码:37 / 37
相关论文
共 50 条
  • [1] CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
    Koppel, Jeremy
    Vingtdeux, Valerie
    Marambaud, Philippe
    d'Abramo, Cristina
    Jimenez, Heidy
    Stauber, Mark
    Friedman, Rachel
    Davies, Peter
    MOLECULAR MEDICINE, 2013, 19 : 357 - 364
  • [2] CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy Koppel
    Valerie Vingtdeux
    Philippe Marambaud
    Cristina d’Abramo
    Heidy Jimenez
    Mark Stauber
    Rachel Friedman
    Peter Davies
    Molecular Medicine, 2013, 19 : 29 - 36
  • [3] CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
    Koppel, Jeremy
    Vingtdeux, Valerie
    Marambaud, Philippe
    d'Abramo, Cristina
    Jimenez, Heidy
    Stauber, Mark
    Friedman, Rachel
    Davies, Peter
    MOLECULAR MEDICINE, 2014, 20 : 29 - 36
  • [4] CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy Koppel
    Valerie Vingtdeux
    Philippe Marambaud
    Cristina d’Abramo
    Heidy Jimenez
    Mark Stauber
    Rachel Friedman
    Peter Davies
    Molecular Medicine, 2014, 20 : 29 - 36
  • [5] CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease (vol 19, pg 357, 2013)
    Koppel, Jeremy
    MOLECULAR MEDICINE, 2014, 20 : 37 - 37
  • [6] CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
    Solas, Maite
    Francis, Paul T.
    Franco, Rafael
    Ramirez, Maria J.
    NEUROBIOLOGY OF AGING, 2013, 34 (03) : 805 - 808
  • [7] CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
    Naert, Gaelle
    Rivest, Serge
    JOURNAL OF NEUROSCIENCE, 2011, 31 (16): : 6208 - 6220
  • [8] Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
    Daniel Paris
    Nowell J Ganey
    Vincent Laporte
    Nikunj S Patel
    David Beaulieu-Abdelahad
    Corbin Bachmeier
    Amelia March
    Ghania Ait-Ghezala
    Michael J Mullan
    Journal of Neuroinflammation, 7
  • [9] Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
    Paris, Daniel
    Ganey, Nowell J.
    Laporte, Vincent
    Patel, Nikunj S.
    Beaulieu-Abdelahad, David
    Bachmeier, Corbin
    March, Amelia
    Ait-Ghezala, Ghania
    Mullan, Michael J.
    JOURNAL OF NEUROINFLAMMATION, 2010, 7
  • [10] SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease
    Capsoni, Simona
    Carlo, Anne-Sophie
    Vignone, Domenico
    Amato, Gianluca
    Criscuolo, Chiara
    Willnow, Thomas E.
    Cattaneo, Antonino
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (02) : 357 - 371